NO20021788D0 - Fremgangsmåte for fremstilling av ulcerterapeutika - Google Patents

Fremgangsmåte for fremstilling av ulcerterapeutika

Info

Publication number
NO20021788D0
NO20021788D0 NO20021788A NO20021788A NO20021788D0 NO 20021788 D0 NO20021788 D0 NO 20021788D0 NO 20021788 A NO20021788 A NO 20021788A NO 20021788 A NO20021788 A NO 20021788A NO 20021788 D0 NO20021788 D0 NO 20021788D0
Authority
NO
Norway
Prior art keywords
preparation
ulcer therapeutics
ulcer
therapeutics
Prior art date
Application number
NO20021788A
Other languages
English (en)
Other versions
NO20021788L (no
NO322802B1 (no
Inventor
Hartmut Loebermann
Karl-Heinz Caster
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO20021788L publication Critical patent/NO20021788L/no
Publication of NO20021788D0 publication Critical patent/NO20021788D0/no
Publication of NO322802B1 publication Critical patent/NO322802B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021788A 1999-10-28 2002-04-16 Fremgangsmate for fremstilling av ulcerterapeutika NO322802B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951960A DE19951960C2 (de) 1999-10-28 1999-10-28 Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
PCT/EP2000/010580 WO2001030765A2 (de) 1999-10-28 2000-10-27 Verfahren zur herstellung von ulkustherapeutika

Publications (3)

Publication Number Publication Date
NO20021788L NO20021788L (no) 2002-04-16
NO20021788D0 true NO20021788D0 (no) 2002-04-16
NO322802B1 NO322802B1 (no) 2006-12-11

Family

ID=7927180

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021788A NO322802B1 (no) 1999-10-28 2002-04-16 Fremgangsmate for fremstilling av ulcerterapeutika

Country Status (27)

Country Link
US (1) US6686474B2 (no)
EP (1) EP1226125B1 (no)
JP (1) JP2003512458A (no)
KR (1) KR100799472B1 (no)
CN (1) CN1227247C (no)
AR (1) AR029401A1 (no)
AT (1) ATE284873T1 (no)
AU (1) AU780944B2 (no)
BR (1) BR0015220A (no)
CA (1) CA2389163C (no)
CZ (1) CZ20021467A3 (no)
DE (2) DE19951960C2 (no)
DK (1) DK1226125T3 (no)
ES (1) ES2234691T3 (no)
HK (1) HK1048805B (no)
HU (1) HUP0203232A3 (no)
IL (2) IL149358A0 (no)
MX (1) MXPA02004116A (no)
NO (1) NO322802B1 (no)
NZ (1) NZ518699A (no)
PE (1) PE20010762A1 (no)
PL (1) PL212931B1 (no)
PT (1) PT1226125E (no)
SI (1) SI1226125T1 (no)
SK (1) SK287227B6 (no)
WO (1) WO2001030765A2 (no)
ZA (1) ZA200204204B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101276915B1 (ko) 2004-09-13 2013-06-19 다케다 야쿠힌 고교 가부시키가이샤 산화 화합물 제조 방법 및 제조 장치
KR100771659B1 (ko) * 2005-03-23 2007-10-30 주식회사 카이로제닉스 판토프라졸 및 그 중간체의 제조방법
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485869A (en) * 1967-01-31 1969-12-23 Fmc Corp Production of organic peroxy acids
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4619997A (en) * 1984-09-06 1986-10-28 The Upjohn Company Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
JPS62108879A (ja) * 1985-11-05 1987-05-20 Grelan Pharmaceut Co Ltd 置換ベンズイミダゾ−ル類
JPS62201884A (ja) * 1986-02-28 1987-09-05 Tokyo Tanabe Co Ltd ベンズイミダゾール誘導体及びその製造法
JPH0717631B2 (ja) * 1986-03-04 1995-03-01 武田薬品工業株式会社 ピリジニウム誘導体およびその製造法
JPS63183577A (ja) * 1987-01-23 1988-07-28 Grelan Pharmaceut Co Ltd ベンズイミダゾ−ル誘導体
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
JPH01294673A (ja) * 1988-05-23 1989-11-28 Grelan Pharmaceut Co Ltd ベンズイミダゾール誘導体
GB2239453A (en) * 1989-11-27 1991-07-03 Haessle Ab Omeprazole
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
FR2701260B1 (fr) * 1993-02-05 1995-05-05 Esteve Labor Dr Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
SK283805B6 (sk) * 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
WO2000053752A2 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
JPH1171371A (ja) * 1997-07-23 1999-03-16 Eisai Co Ltd ピリジン誘導体の製造方法
GB9805558D0 (en) * 1998-03-17 1998-05-13 Knoll Ag Chemical process`
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
JP3926936B2 (ja) * 1998-11-16 2007-06-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホキシド誘導体・アセトン錯体およびその製造法

Also Published As

Publication number Publication date
DE50008978D1 (de) 2005-01-20
CA2389163C (en) 2009-09-15
CA2389163A1 (en) 2001-05-03
JP2003512458A (ja) 2003-04-02
AU780944B2 (en) 2005-04-28
NO20021788L (no) 2002-04-16
DE19951960C2 (de) 2002-06-27
PT1226125E (pt) 2005-04-29
ATE284873T1 (de) 2005-01-15
CN1413204A (zh) 2003-04-23
AU1388401A (en) 2001-05-08
HUP0203232A2 (hu) 2003-02-28
MXPA02004116A (es) 2002-10-17
PL212931B1 (pl) 2012-12-31
KR100799472B1 (ko) 2008-01-30
HUP0203232A3 (en) 2004-01-28
NO322802B1 (no) 2006-12-11
WO2001030765A3 (de) 2001-11-08
EP1226125A2 (de) 2002-07-31
WO2001030765A2 (de) 2001-05-03
CN1227247C (zh) 2005-11-16
ZA200204204B (en) 2003-08-27
ES2234691T3 (es) 2005-07-01
AR029401A1 (es) 2003-06-25
BR0015220A (pt) 2002-06-18
PL355370A1 (en) 2004-04-19
HK1048805A1 (en) 2003-04-17
HK1048805B (zh) 2005-06-30
EP1226125B1 (de) 2004-12-15
IL149358A (en) 2008-11-26
NZ518699A (en) 2004-11-26
IL149358A0 (en) 2002-11-10
DE19951960A1 (de) 2001-05-10
PE20010762A1 (es) 2001-09-08
DK1226125T3 (da) 2005-01-24
CZ20021467A3 (cs) 2002-07-17
SK5892002A3 (en) 2002-09-10
US20020183363A1 (en) 2002-12-05
US6686474B2 (en) 2004-02-03
SI1226125T1 (en) 2005-06-30
SK287227B6 (sk) 2010-03-08
KR20020057984A (ko) 2002-07-12

Similar Documents

Publication Publication Date Title
NO20015017L (no) Fremgangsmate for fremstilling av citalopram
FI20010154A (fi) Menetelmä citalopramin valmistamiseksi
NO20010319L (no) Fremgangsmate for fremstilling av Citalopram
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20011936L (no) Fremgangsmate for fremstilling av citalopram
EE200100536A (et) Amiini-plaatina komplekside valmistamismeetod
NO20013942D0 (no) Fremgangsmate for fremstilling av Citalopram
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20013995L (no) Fremgangsmåte for fremstilling av L-sorbose
NO20021788D0 (no) Fremgangsmåte for fremstilling av ulcerterapeutika
NO20022956D0 (no) Fremgangsmåte for fremstilling av nitroguanidin
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO991679L (no) Fremgangsmaate for fremstilling av fenoksyfenylsulfonylhalider
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
FI20070687A (fi) Menetelmä sitalopraamin valmistamiseksi
EE200200053A (et) Isoretinoiini valmistamise protsess
NO20022671D0 (no) Fremgangsmåte for fremstilling av tienopyrimidiner
FI991618A (fi) Menetelmä massan valmistamiseksi
SE9901814D0 (sv) Förfarande avseende framställning av granuler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees